P/E ratio for Haemonetics (HAE)

P/E ratio history for Haemonetics from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Thermo Fisher Scientific TMO	28.1	18.14%	🇺🇸 USA
Stryker Corporation SYK	52.4	120.17%	🇺🇸 USA
Becton Dickinson BDX	36.5	53.06%	🇺🇸 USA
Cerus CERS	-4.72	-119.84%	🇺🇸 USA
Baxter BAX	5.78	-75.73%	🇺🇸 USA
PerkinElmer PKI	15.0	-37.16%	🇺🇸 USA
Johnson & Johnson JNJ	11.0	-53.68%	🇺🇸 USA
Medtronic MDT	30.8	29.28%	🇮🇪 Ireland

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.